These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 33879723

  • 1. Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis.
    Cao S, He T, Xie J, Feng H, Liu K, Qu B, Wu X.
    Medicine (Baltimore); 2021 Apr 23; 100(16):e25599. PubMed ID: 33879723
    [Abstract] [Full Text] [Related]

  • 2. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C, Tang W, Ren T, Chen Q, Lu R, Gao Y.
    J Endovasc Ther; 2024 Jun 23; 31(3):390-399. PubMed ID: 36189843
    [Abstract] [Full Text] [Related]

  • 3. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):439-446. PubMed ID: 31816169
    [Abstract] [Full Text] [Related]

  • 4. Systematic Review and Meta-Analysis of Drug-Coated Balloon Angioplasty for In-Stent Restenosis in Femoropopliteal Artery Disease.
    Zhen Y, Ren H, Chen J, Chang Z, Wang C, Zheng J.
    J Vasc Interv Radiol; 2022 Apr 15; 33(4):368-374.e6. PubMed ID: 34915164
    [Abstract] [Full Text] [Related]

  • 5. Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis.
    Tong Z, Guo L, Qi L, Cui S, Gao X, Li Y, Guo J, Gu Y.
    Biomed Res Int; 2020 Apr 15; 2020():3076346. PubMed ID: 32596293
    [Abstract] [Full Text] [Related]

  • 6. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
    He Z, Wang H, Lin F, Ding W, Chen K, Zhang Z.
    Vasc Med; 2022 Jun 15; 27(3):239-250. PubMed ID: 35164613
    [Abstract] [Full Text] [Related]

  • 7. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S, Wolf F, Ingwersen M, Kinstner CM, Fusaro M, Ndrepepa G, Ibrahim T, Ott I, Lammer J, Krankenberg H, Fusaro M.
    Circ Cardiovasc Interv; 2018 Dec 15; 11(12):e007055. PubMed ID: 30562083
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
    Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P, Colon-Hernandez PJ, Stark MA, Walker C, EXCITE ISR Investigators.
    JACC Cardiovasc Interv; 2015 Jan 15; 8(1 Pt A):92-101. PubMed ID: 25499305
    [Abstract] [Full Text] [Related]

  • 9. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials.
    Anantha-Narayanan M, Shah SM, Jelani QU, Garcia S, Ionescu C, Regan C, Mena-Hurtado C.
    Catheter Cardiovasc Interv; 2019 Jul 01; 94(1):139-148. PubMed ID: 30838719
    [Abstract] [Full Text] [Related]

  • 10. Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.
    Cassese S, Ndrepepa G, Kufner S, Byrne RA, Giacoppo D, Ott I, Laugwitz KL, Schunkert H, Kastrati A, Fusaro M.
    EuroIntervention; 2017 Jul 20; 13(4):483-489. PubMed ID: 28169215
    [Abstract] [Full Text] [Related]

  • 11. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E.
    J Vasc Surg; 2019 Sep 20; 70(3):981-995.e10. PubMed ID: 31126769
    [Abstract] [Full Text] [Related]

  • 12. Diabetes mellitus and femoropopliteal in-stent restenosis.
    Voll F, Wolf F, Ingwersen M, Kinstner CM, Kufner S, Ibrahim T, Ott I, Krankenberg H, Fusaro M, Cassese S.
    Vasa; 2022 Jul 20; 51(4):247-255. PubMed ID: 35543439
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis.
    Wu R, Li Z, Wang M, Chang G, Yao C, Wang S.
    Int J Surg; 2017 Jun 20; 42():72-82. PubMed ID: 28461145
    [Abstract] [Full Text] [Related]

  • 14. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG, Hossain P, Jawaid O, Alvandi B, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ.
    J Endovasc Ther; 2018 Feb 20; 25(1):81-88. PubMed ID: 29219030
    [Abstract] [Full Text] [Related]

  • 15. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ.
    Cardiovasc Revasc Med; 2020 Jun 20; 21(6):771-778. PubMed ID: 31761634
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G, Schroeder H, Albrecht T, Reimer P, Diehm N, Baeriswyl JL, Brechtel K, Speck U, Zeller T.
    J Endovasc Ther; 2020 Apr 20; 27(2):276-286. PubMed ID: 32096451
    [Abstract] [Full Text] [Related]

  • 17. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
    Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Pérez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, Baan J, Cuesta J, Park DW, Kukla P, Jiménez-Quevedo P, Unverdorben M, Gao R, Naber CK, Park SJ, Henriques JPS, Kastrati A, Byrne RA.
    J Am Coll Cardiol; 2020 Jun 02; 75(21):2664-2678. PubMed ID: 32466881
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
    Koch T, Cassese S, Xhepa E, Mayer K, Tölg R, Hoppmann P, Laugwitz KL, Byrne RA, Kastrati A, Kufner S.
    Catheter Cardiovasc Interv; 2020 Nov 02; 96(5):1008-1015. PubMed ID: 31789486
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
    Zhou Y, Wang J, He H, Li Q, Li M, Li X, Shu C.
    Int J Cardiol; 2021 Nov 15; 343():122-130. PubMed ID: 34461162
    [Abstract] [Full Text] [Related]

  • 20. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.
    Shammas NW, Jones-Miller S, Shammas GA, Shammas WJ.
    J Invasive Cardiol; 2020 Aug 15; 32(8):289-294. PubMed ID: 32737264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.